DY
RXDX

Dowling & Yahnke’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Dowling & Yahnke’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.75M Hold
29,613
– – 0.08% 187
2022
Q2 		$836K Buy
29,613
+5,730
+24% +$162K 0.04% 232
2022
Q1 		$902K Hold
23,883
– – 0.04% 233
2021
Q4 		$944K Buy
+23,883
New +$944K 0.05% 229